Activin type II receptor ligand signaling inhibition after experimental ischemic heart failure attenuates cardiac remodeling and prevents fibrosis.
Castillero E, Akashi H, Najjar M, Ji R, Brandstetter LM, Wang C, Liao X, Zhang X, Sperry A, Gailes M, Guaman K, Recht A, Schlosberg I, Sweeney HL, Ali ZA, Homma S, Colombo PC, Ferrari G, Schulze PC, George I.
Castillero E, et al. Among authors: ji r.
Am J Physiol Heart Circ Physiol. 2020 Feb 1;318(2):H378-H390. doi: 10.1152/ajpheart.00302.2019. Epub 2019 Dec 30.
Am J Physiol Heart Circ Physiol. 2020.
PMID: 31886717
Free PMC article.